drugset / Trial / NCT00849797
Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the rate and extent of absorption of a test formulation of oxcarbazepine tablets and Trileptal® tablets administered as a 1 x 600 mg dose under fed conditions.
Timeline
- Start
- 2005-07
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxcarbazepine | Small molecule | 600 mg | — |
Indications
No indication recorded.